Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis.

[1]  P. Zanen,et al.  Response to pneumococcal vaccination in mannose‐binding lectin‐deficient adults with recurrent respiratory tract infections , 2014, Clinical and experimental immunology.

[2]  D. Dolfi,et al.  Bystander chronic infection negatively impacts development of CD8(+) T cell memory. , 2014, Immunity.

[3]  D. Denning,et al.  Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  E. Wherry,et al.  Chronic bystander infections and immunity to unrelated antigens. , 2012, Cell host & microbe.

[5]  D. Denning,et al.  Mannose‐binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis , 2012, International journal of immunogenetics.

[6]  C. Rice,et al.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. , 2011, Blood.

[7]  J. Kearney,et al.  Marginal Zone B Cells Regulate Antigen Capture by Marginal Zone Macrophages , 2011, The Journal of Immunology.

[8]  J. Walters,et al.  Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. , 2010, The Cochrane database of systematic reviews.

[9]  K. O'Brien,et al.  Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Denning,et al.  Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma , 2010, European Respiratory Journal.

[11]  R. Noelle,et al.  The immortality of humoral immunity , 2010, Immunological reviews.

[12]  R. George,et al.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.

[13]  J. Poolman,et al.  Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics. , 2009, Vaccine.

[14]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[15]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Harrison,et al.  Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database , 2006, Critical care.

[17]  G. Gislason,et al.  Response to pneumococcal vaccine in chronic obstructive lung disease--the effect of ongoing, systemic steroid treatment. , 2006, Vaccine.

[18]  J. Muñoz,et al.  Clinical efficacy of anti-pneumococcal vaccination in patients with COPD , 2005, Thorax.

[19]  S. Thiel,et al.  Clinical manifestations of mannan-binding lectin deficiency , 2005, Molecular Immunology.

[20]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  David Goldblatt,et al.  Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. , 2003, Vaccine.

[22]  J. Kearney,et al.  Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. , 2002, Immunity.

[23]  Wendy Thomson,et al.  Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. , 2001, The Journal of infectious diseases.

[24]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[25]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  K. Nichol,et al.  Immune function and vaccine responses in healthy advanced elderly patients. , 2000, Archives of internal medicine.

[27]  K. Nichol,et al.  The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. , 1999, Archives of internal medicine.

[28]  R. Thompson,et al.  Safety of revaccination with pneumococcal polysaccharide vaccine. , 1999, JAMA.

[29]  M. Turner,et al.  Mannose binding protein gene mutations associated with unusual and severe infections in adults , 1995, The Lancet.

[30]  A. Ortqvist,et al.  Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. , 1994, Archives of internal medicine.

[31]  D. Musher,et al.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. , 1990, The Journal of infectious diseases.

[32]  C. Aranda,et al.  Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. , 1987, Chest.

[33]  J. Leech,et al.  Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[34]  E. Monninkhof,et al.  Chronic Obstructive Pulmonary Disease Pneumococcal Infection in Patients with Host-Pathogen Interaction during , 2017 .

[35]  J. Voelz.  Chapter 25.A , 2011 .

[36]  J. Walters,et al.  Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. , 2010, The Cochrane database of systematic reviews.

[37]  D. Denning,et al.  Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. , 2009, American journal of respiratory and critical care medicine.

[38]  E. Stanford,et al.  Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. , 2005, Journal of immunological methods.

[39]  Pneumococcal vaccines. WHO position paper. , 1999, Releve epidemiologique hebdomadaire.